Background illustration for clinical trials search

Paid Clinical Trials Norfolk

Discover 379 paid clinical trials in Norfolk, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

for
Hematopoietic Cell Transplantation Recipient, Leukemia,
Location: Norfolk VA, Richmond VA, Greenville NC,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT00736749

Recruiting

Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

for
Lymphatic Malformation
Location: Norfolk VA, Washington D.C. DC, New York NY,
Sponsor: Protara Therapeutics

Sex: All

Age: 0 - 18

Code: NCT05871970

Phase 2, Recruiting

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for
Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma,
Location: Norfolk VA, Charlottesville VA, Washington D.C. DC,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT06368817

Phase 2, Recruiting

A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)

for
Muscular Atrophy, Spinal
Location: Norfolk VA, Charlottesville VA, Philadelphia PA,
Sponsor: Biogen

Sex: All

Age: 3+

Code: NCT06555419

Phase 1, Recruiting

Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy

for
Spinal Muscular Atrophy, Spine Deformity, Scoliosis
Location: Norfolk VA, Charlottesville VA, Philadelphia PA,
Sponsor: Alcyone Therapeutics, Inc

Sex: All

Age: 3+

Code: NCT05866419

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

for
Sickle Cell Disease
Location: Norfolk VA, Richmond VA, Greenville NC, Fairfax VA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 12+

Code: NCT06612268

Phase 3, Recruiting

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

for
Spinal Muscular Atrophy (SMA)
Location: Norfolk VA, Richmond VA, Charlottesville VA, Durham NC,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0+

Code: NCT04174157

Recruiting

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

for
Duchenne Muscular Dystrophy
Location: Norfolk VA, Philadelphia PA, Columbus OH, Toronto,
Sponsor: Solid Biosciences Inc.

Sex: Male

Age: 0 - 17

Code: NCT06138639

Phase 1, Phase 2, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Norfolk VA, Richmond VA, Greenville NC,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase 3, Recruiting

A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

for
Muscular Atrophy, Spinal
Location: Norfolk VA, Chicago IL, Flower Mound TX
Sponsor: Biogen

Sex: All

Age: 0

Code: NCT07221669

Phase 3, Recruiting

Sleep Treatment for Teens (RCT Phase)

for
Sleep Problems, Suicidal Ideation, Suicidal Behavior
Location: Norfolk VA, Piscataway NJ
Sponsor: Rutgers, The State University of New Jersey

Sex: All

Age: 14 - 18

Code: NCT07303959

Recruiting

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort

for
Duchenne Muscular Dystrophy
Location: Norfolk VA, Durham NC, Gainesville FL, Chicago IL,
Sponsor: Sarepta Therapeutics, Inc.

Sex: Male

Age: 2+

Code: NCT04626674

Phase 1, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Norfolk VA, Charlottesville VA, Falls Church VA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

for
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Location: Norfolk VA, Charlottesville VA, Wilmington DE,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT07022678

Phase 3, Recruiting

A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam

for
Spinal Muscular Atrophy
Location: Norfolk VA, Palo Alto CA
Sponsor: Biogen

Sex: All

Age: 15 - 60

Code: NCT07444476

Phase 3, Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Norfolk VA, Richmond VA, Greenville NC, Falls Church VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Norfolk VA, Richmond VA, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Norfolk VA, Richmond VA, Greenville NC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Norfolk VA, Richmond VA, Greenville NC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase 2, Recruiting

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

for
Rheumatic Joint Disease
Location: Norfolk VA, Washington D.C. DC, Durham NC,
Sponsor: Duke University

Sex: All

Age: 0 - 21

Code: NCT02418442

Recruiting